再看甲氧苄啶-磺胺甲恶唑：其在肠外治疗中的作用。 - Suppr

Suppr

超能文献

Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

作者信息

Sattler F R, Remington J S

出版信息

Eur J Clin Microbiol. 1984 Jun;3(3):174-6. doi: 10.1007/BF02014872.

DOI:10.1007/BF02014872

PMID:6332015

Abstract

摘要

相似文献

Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.再看甲氧苄啶-磺胺甲恶唑：其在肠外治疗中的作用。

Eur J Clin Microbiol. 1984 Jun;3(3):174-6. doi: 10.1007/BF02014872.

Sulphonamides and trimethoprim.磺胺类药物和甲氧苄啶。

Lancet. 1982 Aug 14;2(8294):370-3. doi: 10.1016/s0140-6736(82)90557-8.

Trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑

N Engl J Med. 1980 Aug 21;303(8):426-32. doi: 10.1056/NEJM198008213030804.

Therapeutic progress: trimethoprim-sulfamethoxazole.治疗进展：甲氧苄啶-磺胺甲恶唑

Bol Asoc Med P R. 1984 Jul;76(7):309-13.

Trimethoprim-sulfamethoxazole.

Pediatr Clin North Am. 1983 Feb;30(1):27-30. doi: 10.1016/s0031-3955(16)34317-6.

Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明（甲氧苄啶-磺胺甲恶唑）：抗菌活性及临床疗效的最新综述

Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.

Trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑

Mayo Clin Proc. 1987 Oct;62(10):921-9. doi: 10.1016/s0025-6196(12)65049-6.

Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑的静脉药代动力学及体外杀菌活性

Rev Infect Dis. 1982 Mar-Apr;4(2):562-5. doi: 10.1093/clinids/4.2.562.

Intravenous sulfamethoxazole-trimethoprim: pharmacokinetics, therapeutic indications, and adverse reactions.

Pharmacotherapy. 1981 Nov-Dec;1(3):206-11. doi: 10.1002/j.1875-9114.1981.tb02542.x.

Trimethoprim-sulphamethoxazole.甲氧苄啶-磺胺甲恶唑

Indian Pediatr. 1987 Nov;24(11):1035-7.

引用本文的文献

Antibiotic combinations: should they be tested?抗生素联合使用：是否应该进行检测？

Clin Microbiol Rev. 1988 Apr;1(2):139-56. doi: 10.1128/CMR.1.2.139.

Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.抗菌化疗中酶抑制剂的临床药代动力学

Clin Pharmacokinet. 1988 Sep;15(3):133-64. doi: 10.2165/00003088-198815030-00001.

本文引用的文献

Intravenous trimethoprim-sulfamethoxazole alone or combined with tobramycin for infections in cancer patients.

Am J Med Sci. 1980 Jan-Feb;279(1):4-13. doi: 10.1097/00000441-198001000-00001.

Trimethoprim resistance in Finland after five years' use of plain trimethoprim.在单纯使用甲氧苄啶五年后芬兰出现的甲氧苄啶耐药性。

Br Med J. 1980 Jan 12;280(6207):72-4. doi: 10.1136/bmj.280.6207.72.

Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function.

Helv Paediatr Acta. 1981;36(6):579-88.

Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides.甲氧苄啶与磺胺类药物之间协同作用及耐药性的实验室监测。

Rev Infect Dis. 1982 Mar-Apr;4(2):351-7. doi: 10.1093/clinids/4.2.351.

Resistance to trimethoprim in 1978-79 compared with 1973-75.1978 - 1979年与1973 - 1975年相比对甲氧苄啶的耐药性。

J Clin Pathol. 1981 Apr;34(4):439-42. doi: 10.1136/jcp.34.4.439.

Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑的静脉药代动力学及体外杀菌活性

Rev Infect Dis. 1982 Mar-Apr;4(2):562-5. doi: 10.1093/clinids/4.2.562.

Clinical evaluation of intravenous trimethoprim-sulfamethoxazole for serious infections.

Rev Infect Dis. 1982 Mar-Apr;4(2):332-7. doi: 10.1093/clinids/4.2.332.

Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia.使用甲氧苄啶-磺胺甲恶唑治疗诺卡菌属感染。

Rev Infect Dis. 1982 Mar-Apr;4(2):315-25. doi: 10.1093/clinids/4.2.315.

Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.流感嗜血杆菌b型荚膜的形成作为致病性的决定因素以及甲氧苄啶-磺胺甲恶唑对其杀伤作用的损害

J Clin Invest. 1982 Mar;69(3):658-65. doi: 10.1172/jci110493.

In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.甲氧苄啶和磺胺甲恶唑对单核细胞增生李斯特菌的体外活性。

Antimicrob Agents Chemother. 1982 Jul;22(1):51-4. doi: 10.1128/AAC.22.1.51.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验